nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—Cisplatin—urinary bladder cancer	0.341	0.856	CbGbCtD
Oxprenolol—CYP2D6—Doxorubicin—urinary bladder cancer	0.0573	0.144	CbGbCtD
Oxprenolol—Emotional distress—Fluorouracil—urinary bladder cancer	0.0297	0.0494	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.0143	0.0238	CcSEcCtD
Oxprenolol—Abdominal pain—Valrubicin—urinary bladder cancer	0.0124	0.0207	CcSEcCtD
Oxprenolol—Cardiac failure—Thiotepa—urinary bladder cancer	0.0114	0.0189	CcSEcCtD
Oxprenolol—Asthenia—Valrubicin—urinary bladder cancer	0.0113	0.0188	CcSEcCtD
Oxprenolol—Pruritus—Valrubicin—urinary bladder cancer	0.0111	0.0185	CcSEcCtD
Oxprenolol—Diarrhoea—Valrubicin—urinary bladder cancer	0.0108	0.0179	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0106	0.0176	CcSEcCtD
Oxprenolol—Dizziness—Valrubicin—urinary bladder cancer	0.0104	0.0173	CcSEcCtD
Oxprenolol—Headache—Valrubicin—urinary bladder cancer	0.00985	0.0164	CcSEcCtD
Oxprenolol—Cardiac failure—Gemcitabine—urinary bladder cancer	0.00955	0.0159	CcSEcCtD
Oxprenolol—Cardiac failure—Fluorouracil—urinary bladder cancer	0.00939	0.0156	CcSEcCtD
Oxprenolol—Nausea—Valrubicin—urinary bladder cancer	0.00934	0.0155	CcSEcCtD
Oxprenolol—Fatigue—Mitomycin—urinary bladder cancer	0.00934	0.0155	CcSEcCtD
Oxprenolol—Cardiac failure—Etoposide—urinary bladder cancer	0.00816	0.0136	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00794	0.0132	CcSEcCtD
Oxprenolol—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00792	0.0132	CcSEcCtD
Oxprenolol—Asthenia—Mitomycin—urinary bladder cancer	0.00777	0.0129	CcSEcCtD
Oxprenolol—Diarrhoea—Mitomycin—urinary bladder cancer	0.00741	0.0123	CcSEcCtD
Oxprenolol—Sweating increased—Cisplatin—urinary bladder cancer	0.00731	0.0122	CcSEcCtD
Oxprenolol—Dizziness—Mitomycin—urinary bladder cancer	0.00716	0.0119	CcSEcCtD
Oxprenolol—Headache—Mitomycin—urinary bladder cancer	0.00678	0.0113	CcSEcCtD
Oxprenolol—Bronchospasm—Etoposide—urinary bladder cancer	0.00677	0.0112	CcSEcCtD
Oxprenolol—Sweating increased—Etoposide—urinary bladder cancer	0.0067	0.0111	CcSEcCtD
Oxprenolol—Nausea—Mitomycin—urinary bladder cancer	0.00643	0.0107	CcSEcCtD
Oxprenolol—Bradycardia—Cisplatin—urinary bladder cancer	0.00612	0.0102	CcSEcCtD
Oxprenolol—Abnormal dreams—Epirubicin—urinary bladder cancer	0.00607	0.0101	CcSEcCtD
Oxprenolol—Arthralgia—Thiotepa—urinary bladder cancer	0.00568	0.00944	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—urinary bladder cancer	0.00562	0.00934	CcSEcCtD
Oxprenolol—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00533	0.00886	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00496	0.00825	CcSEcCtD
Oxprenolol—Dyspepsia—Thiotepa—urinary bladder cancer	0.00479	0.00797	CcSEcCtD
Oxprenolol—Arthralgia—Gemcitabine—urinary bladder cancer	0.00478	0.00795	CcSEcCtD
Oxprenolol—Fatigue—Thiotepa—urinary bladder cancer	0.0047	0.00781	CcSEcCtD
Oxprenolol—Cardiac failure—Epirubicin—urinary bladder cancer	0.00457	0.0076	CcSEcCtD
Oxprenolol—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00457	0.0076	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00449	0.00746	CcSEcCtD
Oxprenolol—Diplopia—Epirubicin—urinary bladder cancer	0.00446	0.00742	CcSEcCtD
Oxprenolol—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00443	0.00736	CcSEcCtD
Oxprenolol—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00441	0.00733	CcSEcCtD
Oxprenolol—Abdominal pain—Thiotepa—urinary bladder cancer	0.00431	0.00716	CcSEcCtD
Oxprenolol—Hypotension—Gemcitabine—urinary bladder cancer	0.00428	0.00712	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00423	0.00703	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00423	0.00703	CcSEcCtD
Oxprenolol—Hypotension—Fluorouracil—urinary bladder cancer	0.00421	0.007	CcSEcCtD
Oxprenolol—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00418	0.00695	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00417	0.00694	CcSEcCtD
Oxprenolol—Insomnia—Gemcitabine—urinary bladder cancer	0.00414	0.00689	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—urinary bladder cancer	0.00413	0.00686	CcSEcCtD
Oxprenolol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00413	0.00686	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.0041	0.00682	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00407	0.00677	CcSEcCtD
Oxprenolol—Insomnia—Fluorouracil—urinary bladder cancer	0.00407	0.00677	CcSEcCtD
Oxprenolol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00401	0.00667	CcSEcCtD
Oxprenolol—Hypotension—Cisplatin—urinary bladder cancer	0.00399	0.00663	CcSEcCtD
Oxprenolol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00397	0.00659	CcSEcCtD
Oxprenolol—Fatigue—Gemcitabine—urinary bladder cancer	0.00395	0.00657	CcSEcCtD
Oxprenolol—Asthenia—Thiotepa—urinary bladder cancer	0.00391	0.0065	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00389	0.00647	CcSEcCtD
Oxprenolol—Pruritus—Thiotepa—urinary bladder cancer	0.00385	0.00641	CcSEcCtD
Oxprenolol—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00383	0.00637	CcSEcCtD
Oxprenolol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00378	0.00629	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00377	0.00627	CcSEcCtD
Oxprenolol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00373	0.00619	CcSEcCtD
Oxprenolol—Hypotension—Etoposide—urinary bladder cancer	0.00366	0.00608	CcSEcCtD
Oxprenolol—Dizziness—Thiotepa—urinary bladder cancer	0.0036	0.00599	CcSEcCtD
Oxprenolol—Headache—Thiotepa—urinary bladder cancer	0.00341	0.00567	CcSEcCtD
Oxprenolol—Fatigue—Etoposide—urinary bladder cancer	0.00337	0.00561	CcSEcCtD
Oxprenolol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00332	0.00552	CcSEcCtD
Oxprenolol—Asthenia—Gemcitabine—urinary bladder cancer	0.00329	0.00546	CcSEcCtD
Oxprenolol—Pruritus—Gemcitabine—urinary bladder cancer	0.00324	0.00539	CcSEcCtD
Oxprenolol—Nausea—Thiotepa—urinary bladder cancer	0.00323	0.00538	CcSEcCtD
Oxprenolol—Pruritus—Fluorouracil—urinary bladder cancer	0.00319	0.0053	CcSEcCtD
Oxprenolol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00315	0.00523	CcSEcCtD
Oxprenolol—Bradycardia—Epirubicin—urinary bladder cancer	0.00314	0.00522	CcSEcCtD
Oxprenolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00313	0.00521	CcSEcCtD
Oxprenolol—Abdominal pain—Etoposide—urinary bladder cancer	0.00309	0.00514	CcSEcCtD
Oxprenolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00308	0.00512	CcSEcCtD
Oxprenolol—Asthenia—Cisplatin—urinary bladder cancer	0.00306	0.00509	CcSEcCtD
Oxprenolol—Dizziness—Fluorouracil—urinary bladder cancer	0.00298	0.00495	CcSEcCtD
Oxprenolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00292	0.00486	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00291	0.00483	CcSEcCtD
Oxprenolol—Hypersensitivity—Etoposide—urinary bladder cancer	0.00288	0.00479	CcSEcCtD
Oxprenolol—Headache—Gemcitabine—urinary bladder cancer	0.00287	0.00477	CcSEcCtD
Oxprenolol—Headache—Fluorouracil—urinary bladder cancer	0.00282	0.00469	CcSEcCtD
Oxprenolol—Asthenia—Etoposide—urinary bladder cancer	0.00281	0.00467	CcSEcCtD
Oxprenolol—Pruritus—Etoposide—urinary bladder cancer	0.00277	0.0046	CcSEcCtD
Oxprenolol—Nausea—Gemcitabine—urinary bladder cancer	0.00272	0.00452	CcSEcCtD
Oxprenolol—Diarrhoea—Etoposide—urinary bladder cancer	0.00268	0.00445	CcSEcCtD
Oxprenolol—Nausea—Fluorouracil—urinary bladder cancer	0.00268	0.00445	CcSEcCtD
Oxprenolol—Dizziness—Etoposide—urinary bladder cancer	0.00259	0.0043	CcSEcCtD
Oxprenolol—Nausea—Cisplatin—urinary bladder cancer	0.00254	0.00422	CcSEcCtD
Oxprenolol—Headache—Etoposide—urinary bladder cancer	0.00245	0.00407	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—urinary bladder cancer	0.00244	0.00406	CcSEcCtD
Oxprenolol—Palpitations—Epirubicin—urinary bladder cancer	0.00237	0.00395	CcSEcCtD
Oxprenolol—Nausea—Etoposide—urinary bladder cancer	0.00232	0.00386	CcSEcCtD
Oxprenolol—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00229	0.00381	CcSEcCtD
Oxprenolol—Arthralgia—Epirubicin—urinary bladder cancer	0.00229	0.0038	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00227	0.00377	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—urinary bladder cancer	0.0022	0.00365	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—urinary bladder cancer	0.00219	0.00364	CcSEcCtD
Oxprenolol—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00215	0.00357	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00213	0.00355	CcSEcCtD
Oxprenolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00212	0.00352	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—urinary bladder cancer	0.00212	0.00352	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—urinary bladder cancer	0.00212	0.00352	CcSEcCtD
Oxprenolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.00206	0.00343	CcSEcCtD
Oxprenolol—Hypotension—Epirubicin—urinary bladder cancer	0.00205	0.00341	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—urinary bladder cancer	0.00202	0.00336	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.002	0.00332	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00199	0.0033	CcSEcCtD
Oxprenolol—Insomnia—Epirubicin—urinary bladder cancer	0.00198	0.0033	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00196	0.00326	CcSEcCtD
Oxprenolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.00193	0.00321	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—urinary bladder cancer	0.0019	0.00315	CcSEcCtD
Oxprenolol—Fatigue—Epirubicin—urinary bladder cancer	0.00189	0.00314	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00185	0.00308	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00185	0.00307	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—urinary bladder cancer	0.00184	0.00305	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00179	0.00297	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—urinary bladder cancer	0.00175	0.00291	CcSEcCtD
Oxprenolol—Abdominal pain—Epirubicin—urinary bladder cancer	0.00173	0.00288	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00173	0.00287	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—urinary bladder cancer	0.00168	0.0028	CcSEcCtD
Oxprenolol—Pruritus—Methotrexate—urinary bladder cancer	0.00166	0.00276	CcSEcCtD
Oxprenolol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00162	0.00269	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.0016	0.00267	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.0016	0.00267	CcSEcCtD
Oxprenolol—Asthenia—Epirubicin—urinary bladder cancer	0.00157	0.00262	CcSEcCtD
Oxprenolol—Pruritus—Epirubicin—urinary bladder cancer	0.00155	0.00258	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—urinary bladder cancer	0.00155	0.00258	CcSEcCtD
Oxprenolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.0015	0.00249	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00149	0.00249	CcSEcCtD
Oxprenolol—Headache—Methotrexate—urinary bladder cancer	0.00147	0.00244	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—urinary bladder cancer	0.00146	0.00242	CcSEcCtD
Oxprenolol—Dizziness—Epirubicin—urinary bladder cancer	0.00145	0.00241	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—urinary bladder cancer	0.00144	0.00239	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—urinary bladder cancer	0.00139	0.00231	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00139	0.00231	CcSEcCtD
Oxprenolol—Headache—Epirubicin—urinary bladder cancer	0.00137	0.00228	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—urinary bladder cancer	0.00134	0.00223	CcSEcCtD
Oxprenolol—Nausea—Epirubicin—urinary bladder cancer	0.0013	0.00217	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—urinary bladder cancer	0.00127	0.00211	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—urinary bladder cancer	0.00121	0.002	CcSEcCtD
